ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9461
0.01%
Brent Oil
83.895
0.42%
Bitcoin
57,440.47
-1.37%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Immunic Inc (IMUX)

  7. Immunic Inc (IMUX) Noticias

IMUX Immunic Inc

1.2709
0.0109 (0.87%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Immunic Inc IMUX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0109 0.87% 1.2709 17:33:43
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.29 1.26 1.34 1.30 1.26
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202405:30PRNUSImmunic, Inc. to Announce Financial Results for the First..
30/4/202405:30PRNUSImmunic Announces Publication of Extended Data From Phase 2..
04/4/202405:30PRNUSImmunic to Host MS R&D Day and Participate in Investor..
20/3/202405:30PRNUSImmunic Receives Notice of Allowance for..
08/3/202415:05EDGAR2Form 8-K - Current report
07/3/202405:30PRNUSImmunic to Participate in Investor and Scientific..
06/3/202420:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202420:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202420:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202405:30PRNUSImmunic Presents Data From Phase 2 CALLIPER and CALVID-1..
22/2/202405:38EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202405:35EDGAR2Form 8-K - Current report
22/2/202405:30PRNUSImmunic, Inc. Reports Year End 2023 Financial Results and..
15/2/202405:30PRNUSImmunic, Inc. to Announce Financial Results for the Year..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202406:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:36EDGAR2Form S-3 - Registration statement under Securities Act of..
05/2/202407:30EDGAR2Form DEF 14A - Other definitive proxy statements
01/2/202405:30PRNUSImmunic to Participate in Investor and Scientific..
24/1/202416:05EDGAR2Form PRE 14A - Other preliminary proxy statements
19/1/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:05EDGAR2Form D - Notice of Exempt Offering of Securities
16/1/202415:12EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/1/202408:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/1/202405:41EDGAR2Form 8-K - Current report
05/1/202405:35PRNUSImmunic Highlights 2023 Accomplishments and Upcoming..
05/1/202405:30PRNUSImmunic, Inc. Announces Private Placement of up to $240..
21/12/202307:30EDGAR2Form 8-K - Current report
22/11/202315:20EDGAR2Form S-3 - Registration statement under Securities Act of..
21/11/202305:30PRNUSImmunic Receives Notice of Allowance for United States..
14/11/202305:38EDGAR2Form 8-K - Current report
14/11/202305:30PRNUSImmunic, Inc. Reports Third Quarter 2023 Financial Results..
07/11/202305:30PRNUSImmunic to Announce Financial Results for the Third Quarter..
02/11/202305:30PRNUSImmunic Receives Notice of Allowance for United States..
26/10/202305:30PRNUSImmunic to Participate in Scientific and Industry..
18/10/202315:05EDGAR2Form 8-K - Current report
16/10/202305:30PRNUSImmunic Presents Data From Phase 2 CALDOSE-1 Trial of..
15/10/202305:30PRNUSImmunic Presents Data From Phase 1b Clinical Trial of..
11/10/202305:30PRNUSImmunic Presents Data From Phase 2 EMPhASIS Trial of..
10/10/202307:48EDGAR2Form 8-K - Current report
09/10/202315:01PRNUSImmunic Reports Positive Interim Data from Phase 2 CALLIPER..
04/10/202305:30PRNUSImmunic to Participate in Scientific Conferences in October
06/9/202305:30PRNUSImmunic to Participate in Industry and Investor Conferences..

Su Consulta Reciente

NASDAQ
IMUX
Immunic
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados